124 related articles for article (PubMed ID: 7509607)
1. Lack of ACTH/cortisol and GH responses to intravenously-infused substance P in Parkinson's disease.
Volpi R; Caffarra P; Scaglioni A; Saginario A; Maestri D; Vourna S; Vescovi PP; Chiodera P; Coiro V
J Neural Transm Park Dis Dement Sect; 1993; 6(2):99-107. PubMed ID: 7509607
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of ACTH/cortisol by intravenously infused substance P in normal men: inhibition by sodium valproate.
Coiro V; Capretti L; Volpi R; Davoli C; Marcato A; Cavazzini U; Caffarri G; Rossi G; Chiodera P
Neuroendocrinology; 1992 Oct; 56(4):459-63. PubMed ID: 1282218
[TBL] [Abstract][Full Text] [Related]
3. Intravenously infused substance P enhances basal and growth hormone (GH) releasing hormone-stimulated GH secretion in normal men.
Coiro V; Volpi R; Capretti L; Speroni G; Bocchi R; Caffarri G; Colla R; Rossi G; Chiodera P
Peptides; 1992; 13(4):843-6. PubMed ID: 1279634
[TBL] [Abstract][Full Text] [Related]
4. Reduced ACTH/cortisol responses to naloxone in men with Parkinson's disease.
Volpi R; Caffarra P; Marcato A; Scaglioni A; Maestri D; Delsignore R; Chiodera P; Coiro V
J Neural Transm Park Dis Dement Sect; 1991; 3(2):127-32. PubMed ID: 1654925
[TBL] [Abstract][Full Text] [Related]
5. Plasma profiles of adrenocorticotropic hormone, cortisol, growth hormone and prolactin in patients with untreated Parkinson's disease.
Bellomo G; Santambrogio L; Fiacconi M; Scarponi AM; Ciuffetti G
J Neurol; 1991 Feb; 238(1):19-22. PubMed ID: 1851513
[TBL] [Abstract][Full Text] [Related]
6. Luteinizing hormone response to an intravenous infusion of substance P in normal men.
Coiro V; Volpi R; Capretti L; Caiazza A; Marcato A; Bocchi R; Colla R; Rossi G; Chiodera P
Metabolism; 1992 Jul; 41(7):689-91. PubMed ID: 1377769
[TBL] [Abstract][Full Text] [Related]
7. Intravenously infused substance P is unable to change basal and TRH-stimulated PRL secretion in normal men.
Coiro V; Volpi R; Capretti L; Caiazza A; Caffarri G; Rossi G; Marchesi C; Chiodera P
Horm Res; 1993; 39(1-2):73-6. PubMed ID: 7691703
[TBL] [Abstract][Full Text] [Related]
8. The effect of oxytocin infusion on adenohypophysial and adrenal cortical responses to insulin-induced hypoglycaemia.
Nussey SS; Page SR; Ang VT; Jenkins JS; White A
Clin Endocrinol (Oxf); 1988 Sep; 29(3):257-64. PubMed ID: 2855220
[TBL] [Abstract][Full Text] [Related]
9. Interaction of the growth hormone releasing peptide hexarelin with somatostatin.
Massoud AF; Hindmarsh PC; Brook CG
Clin Endocrinol (Oxf); 1997 Nov; 47(5):537-47. PubMed ID: 9425393
[TBL] [Abstract][Full Text] [Related]
10. Restoration of ACTH/cortisol and LH responses to naloxone by chronic dopaminergic treatment in Parkinson's disease.
Volpi R; Caffarra P; Scaglioni A; Maestri D; Chiodera P; Coiro V
J Neural Transm Park Dis Dement Sect; 1994; 7(1):1-11. PubMed ID: 8579765
[TBL] [Abstract][Full Text] [Related]
11. Free fatty acids inhibit adrenocorticotropin and cortisol secretion stimulated by physical exercise in normal men.
Coiro V; Casti A; Rubino P; Manfredi G; Maffei ML; Melani A; Saccani Jotti G; Chiodera P
Clin Endocrinol (Oxf); 2007 May; 66(5):740-3. PubMed ID: 17381494
[TBL] [Abstract][Full Text] [Related]
12. Comparison of adrenocorticotropin (ACTH) stimulation tests and insulin hypoglycemia in normal humans: low dose, standard high dose, and 8-hour ACTH-(1-24) infusion tests.
Nye EJ; Grice JE; Hockings GI; Strakosch CR; Crosbie GV; Walters MM; Jackson RV
J Clin Endocrinol Metab; 1999 Oct; 84(10):3648-55. PubMed ID: 10523009
[TBL] [Abstract][Full Text] [Related]
13. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
[TBL] [Abstract][Full Text] [Related]
14. Responses of plasma adrenocorticotropin and cortisol to intravenous injection of synthetic ovine corticotropin releasing factor in the morning and early evening in normal human subjects.
Watabe T; Tanaka K; Hasegawa M; Miyabe S; Shimizu N
Endocrinol Jpn; 1985 Oct; 32(5):771-9. PubMed ID: 3004929
[TBL] [Abstract][Full Text] [Related]
15. Effect of substance P on basal and thyrotropin-releasing hormone-stimulated thyrotropin release in humans.
Coiro V; Volpi R; Capretti L; Gramellini D; Cigarini C; Papadia C; Caiazza A; Caffarri G; Caffarra P; Chiodera P
Metabolism; 1995 Apr; 44(4):474-7. PubMed ID: 7536884
[TBL] [Abstract][Full Text] [Related]
16. Effect of atrial natriuretic factor infusion on basal and CRH-stimulated ACTH, cortisol and aldosterone levels in patients with Cushing's or Addison's disease.
Ambrosi B; Sala C; Bochicchio D; Colombo P; Gazzano G; Fadin C; Morganti A; Faglia G
Clin Endocrinol (Oxf); 1994 May; 40(5):589-94. PubMed ID: 8013139
[TBL] [Abstract][Full Text] [Related]
17. Opioid modulation of the effects of repeated stress on ACTH, cortisol, prolactin, and growth hormone in pigs.
Rushen J; Schwarze N; Ladewig J; Foxcroft G
Physiol Behav; 1993 May; 53(5):923-8. PubMed ID: 8390062
[TBL] [Abstract][Full Text] [Related]
18. ACTH/cortisol involvement in the serotonergic disorder affecting the parkinsonian brain.
Volpi R; Caffarra P; Boni S; Scaglioni A; Malvezzi L; Saginario A; Chiodera P; Coiro V
Neuropsychobiology; 1997; 35(2):73-8. PubMed ID: 9097297
[TBL] [Abstract][Full Text] [Related]
19. Human corticotropin-releasing factor in man: pharmacokinetic properties and dose-response of plasma adrenocorticotropin and cortisol secretion.
Schürmeyer TH; Avgerinos PC; Gold PW; Gallucci WT; Tomai TP; Cutler GB; Loriaux DL; Chrousos GP
J Clin Endocrinol Metab; 1984 Dec; 59(6):1103-8. PubMed ID: 6092407
[TBL] [Abstract][Full Text] [Related]
20. Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans.
Broglio F; Prodam F; Gottero C; Destefanis S; Me E; Riganti F; Giordano R; Picu A; Balbo M; Van der Lely AJ; Ghigo E; Arvat E
Clin Endocrinol (Oxf); 2004 Jun; 60(6):699-704. PubMed ID: 15163333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
